Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Arnicolide D is a sesquiterpene lactone that has been found in Centipeda minima and has anticancer activity.1 It inhibits the proliferation of MDA-MB-231, MDA-MB-468, and MCF-7 human breast cancer cells (IC50s = 5.211, 3.405, and 9.083 µM, respectively, after 48 hours). It induces apoptosis and cell cycle arrest at the G2/M phase in MDA-MB-468 and MDA-MB-231 cells. Arnicolide D (2.5, 5, and 10 µM) inhibits migration of MDA-MB-231 cells. It also reduces protein levels of Akt, phosphorylated Akt, mammalian target of rapamycin (mTOR), phosphorylated mTOR, and STAT3 in MDA-MB-231 cells in a concentration-dependent manner. Arnicolide D (25 or 50 mg/kg) reduces tumor volume in an MDA-MB-231 orthotopic mouse xenograft model.
WARNING This product is not for human or veterinary use.
1. Arnicolide D inhibits triple negative breast cancer cell proliferation by suppression of AKT/mTOR and STAT3 signaling pathways. Int. J. Med. Chem. 17(11), 1482-1490 (2020).